Edition:
United Kingdom

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

3,155JPY
2 Dec 2016
Change (% chg)

¥-50 (-1.56%)
Prev Close
¥3,205
Open
¥3,180
Day's High
¥3,195
Day's Low
¥3,115
Volume
1,510,900
Avg. Vol
1,164,615
52-wk High
¥4,685
52-wk Low
¥3,110

4519.T

Chart for 4519.T

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ¥1,852,560.00
Shares Outstanding(Mil.): 559.69
Dividend: 26.00
Yield (%): 1.57

Financials

  4519.T Industry Sector
P/E (TTM): 32.01 29.13 29.87
EPS (TTM): 103.40 -- --
ROI: 8.83 15.56 14.95
ROE: 9.09 16.69 16.29

BRIEF-Chugai, Berlin-Chemie Menarini set license agreement for PA799

* Roche's chugai and Berlin-Chemie Menarini Group announce global license agreement for an anti-cancer agent PA799 Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

28 Nov 2016

BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab

* Chugai will continue to be responsible for product manufacturing and supply of Nemolizumab.

21 Jul 2016

Earnings vs. Estimates